Why Invest In Exact Sciences Corp (EXAS) Stock?
Exact Sciences Corp (NASDAQ:EXAS) has a beta value of 0.89 and has seen 0.54 million shares traded in the recent trading session. The company, currently
Exact Sciences Corp (NASDAQ:EXAS) has a beta value of 0.89 and has seen 0.54 million shares traded in the recent trading session. The company, currently
Flex Ltd (NASDAQ:FLEX) has a beta value of 0.98 and has seen 1.32 million shares traded in the recent trading session. The company, currently valued
Valaris Ltd (NYSE:VAL) has a beta value of 1.16 and has seen 0.69 million shares traded in the recent trading session. The company, currently valued
Stanley Black & Decker Inc (NYSE:SWK) has a beta value of 1.24 and has seen 0.9 million shares traded in the recent trading session. The
Himax Technologies ADR (NASDAQ:HIMX) has a beta value of 2.15 and has seen 0.49 million shares traded in the recent trading session. The company, currently
Revolution Medicines Inc (NASDAQ:RVMD) has a beta value of 1.08 and has seen 1.07 million shares traded in the recent trading session. The company, currently
GlycoMimetics Inc (NASDAQ:GLYC) has a beta value of 1.64 and has seen 2.77 million shares traded in the recent trading session. The company, currently valued
Tandem Diabetes Care Inc (NASDAQ:TNDM) has a beta value of 1.49 and has seen 0.55 million shares traded in the recent trading session. The company,
BioNTech SE ADR (NASDAQ:BNTX) has a beta value of 1.26 and has seen 1.63 million shares traded in the recent trading session. The company, currently
nVent Electric plc (NYSE:NVT) has a beta value of 1.23 and has seen 0.73 million shares traded in the recent trading session. The company, currently
© 2024, Powered by Smart TechOne